EMAILNCT07932080
Evaluation of the Predictive Value of Microemboli Detected by Robotic Transcranial Doppler (TCD) for the Occurrence of an Acute Ischemic Stroke (AIS) or Left Ventricular Thrombus (LVT) in ST Elevation Myocardial Infarction (STEMI) Patients With Left Ventricular Dysfunction (LVD).
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Study sites: 0 to 1
- Secondary endpoints revised (5)
- Study title expanded, about 8 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Demonstration of a correlation between the number of MES detected and the 2-year risk of AIS or the occurrence of a LVT at 6 weeks in patients with post-STEMI LVD.
Timeframe: To the enrollment period to 2-years of AIS or 6-weeks of a LVT
Secondary (5)
Demonstration of a correlation between the number of MES detected and the treatment given (single anti-aggregation, double anti-aggregation, anti-coagulation) in patients suffering from LVD
Demonstration of a correlation between the variation in the number of MES detected and the modification of the treatment administered (single anti-aggregation, double anti-aggregation, anti-coagulation) in patients suffering from LVD
Demonstration of a correlation between the number of MES and the LVD rate according to the ACCF/AHA Heart Failure classification
Demonstration of correlations between the number of MES detected and the risk of occurrence of an AIS at 2 years or LVT at 6 weeks in patients suffering from LVD, classified by subgroup of cardiac decompensation according to the ACCF/AHA Heart Failure
Creation of a large multicentric prospective follow-up database of patients suffering from LVD, whether symptomatic or not
Arms and interventions
Transcranial DopplerExperimental
Devices: Transcranial doppler (TCD)
Sites
1 site in 1 country
- CHC MontLégiaLiège, Liège, Belgium